OnKure Therapeutics, Inc.
OKUR
$2.82
-$0.015-0.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.95% | -3.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.98% | -4.77% | |||
| Operating Income | 3.98% | 4.77% | |||
| Income Before Tax | 3.36% | 8.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 3.36% | 8.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.36% | 8.70% | |||
| EBIT | 3.98% | 4.77% | |||
| EBITDA | 4.00% | 4.82% | |||
| EPS Basic | 3.97% | 13.12% | |||
| Normalized Basic EPS | 3.97% | 8.05% | |||
| EPS Diluted | 3.97% | 13.12% | |||
| Normalized Diluted EPS | 3.97% | 8.05% | |||
| Average Basic Shares Outstanding | 0.63% | 5.09% | |||
| Average Diluted Shares Outstanding | 0.63% | 5.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||